Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes

Clinical trial NCT02131597 · COMPLETED

Trial details

NCT number: NCT02131597
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

High Risk Myelodysplastic Syndrome

Start date: 2014-11-10
Primary completion: 2024-07-25
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.